Offerings // ORAMED PHARMACEUTICALS INC.

ORMP offering history

Every offering-related filing in ORAMED PHARMACEUTICALS INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 931 filings back to Nov 29, 2002.

Last executed offering

Mar 18, 2024

424B5 — priced deal (shares or notes)

Last registration (announced)

Jul 15, 2021

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Mar 18, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 4, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 1, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 13, 2021	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Jul 26, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 15, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 16, 2021	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
Jun 16, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 10, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 3, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 1, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 2, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 26, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 10, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 10, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 31, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 5, 2019	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 5, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 3, 2017	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Oct 16, 2017	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Aug 28, 2017	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Apr 5, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 2, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 11, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 1, 2016	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Nov 30, 2015	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 5, 2015	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 3, 2015	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 4, 2014	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 21, 2014	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Apr 10, 2014	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 20, 2014	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Feb 3, 2014	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Jan 24, 2014	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 26, 2013	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 9, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 22, 2013	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 9, 2013	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 18, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 18, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

ORMP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ORMP workspace →

ORMP offering FAQ

When did ORMP last execute an offering?

Per SEC filings, ORAMED PHARMACEUTICALS INC.'s most recent priced offering document is a 424B5 filed 2024-03-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ORMP last announce or register an offering?

The most recent registration is a S-3 filed 2021-07-15. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.